Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.03
BATS BZX Real-Time Price
As of 9:59am ET
 -0.03 / -1.46%
Today’s Change
2.03
Today|||52-Week Range
3.95
-42.66%
Year-to-Date
Here's Why PDL BioPharma Inc. Imploded and Fell 32% in November
Dec 02 / MotleyFool.com - Paid Partner Content
Why PDL BioPharma Inc. Is Down 14.8% Today
Nov 23 / MotleyFool.com - Paid Partner Content
3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017
Dec 01 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.06
Today’s open2.07
Day’s range2.03 - 2.07
Volume6,453
Average volume (3 months)1,997,550
Market cap$341.0M
Dividend yield--
Data as of 9:59am ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-73.40%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.01%
P/E ratio1.9
Price/Sales0.99
Price/Book0.49

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.03-0.70%
SELBSelecta Biosciences ...+0.80+3.41%
NVAXNovavax Inc-0.02-1.16%
NDRMNeuroderm Ltd-0.35-1.78%
Data as of 10:03am ET, 12/06/2016

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)$0.09
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts


Search for Jobs